Synlett 2022; 33(14): 1371-1376
DOI: 10.1055/a-1793-1321
cluster
Organic Chemistry in Thailand

Synthesis of Eleven-Membered Cyclic Urea Fused Quinazolinones

Yotsakorn Saebang
,
Juthanat Kaeobamrung
,
Vatcharin Rukachaisirikul
This work was supported by the Thailand Research Fund (Grant Number MRG6180298). Further support was generously provided by the Science Achievement Scholarship of Thailand (SAST) for Mr. Saebang. J. K. also thank the Faculty of Science Research Fund.


Abstract

Straightforward synthesis of quinazolinones having N-fused medium-sized ring urea was accomplished. Key intermediates were tert-butyl {2-[4-oxo-2-(4-oxopentyl)quinazolin-3(4H)-yl]ethyl}carbamates derived from copper-catalyzed domino reaction of tert-butyl [2-(2-iodobenzamido)ethyl]carbamates and cyclic enaminones. Steric hindrance of cyclic enaminones played an important role in the formation of quinazolinone ring. The eleven-membered ring urea moiety was readily achieved by direct cyclization using 1,1′-carbonyldiimidazole (CDI) of diamino intermediate generated by readily reductive amination and deprotection of tert-butyl {2-[4-oxo-2-(4-oxopentyl)quinazolin-3(4H)-yl]ethyl}carbamates.

Supporting Information



Publication History

Received: 14 February 2022

Accepted after revision: 09 March 2022

Accepted Manuscript online:
09 March 2022

Article published online:
20 April 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes

    • 1a Rohokale RS, Kshirsagar UA. Synthesis 2016; 48: 1253
    • 1b Kshirsagar UA. Org. Biomol. Chem. 2015; 13: 9336
    • 1c Tiwary BK, Pradhan K, Nanda AK, Chakraborty R. J. Chem. Biol. Ther. 2015; 1: 104
    • 1d Khan I, Ibrar A, Ahmed W, Saeed A. Eur. J. Med. Chem. 2015; 90: 124
    • 1e Mhaske SB, Argade NP. Tetrahedron 2006; 62: 9787
    • 1f Mahdavi M, Pedrood K, Safavi M, Saeedi M, Pordeli M, Ardestani SK, Emami S, Adib M, Foroumadi A, Shafiee A. Eur. J. Med. Chem. 2015; 95: 492
    • 2a Ma Z.-Z, Hano Y, Nomura T, Chen Y.-J. Heterocycles 1999; 51: 1883
    • 2b Elban MA, Sun W, Eisenhauer BM, Gao R, Hecht SM. Org. Lett. 2006; 8: 3513
    • 2c Thomas CJ, Rahier NJ, Hecht SM. Bioorg. Med. Chem. 2004; 12: 1585
    • 3a Han Y.-Y, Jiang H, Wang R, Yu S. J. Org. Chem. 2016; 81: 7276
    • 3b Shen C, Man NY. T, Stewart S, Wu X.-F. Org. Biomol. Chem. 2015; 13: 4422
    • 3c Servais A, Azzouz M, Lopes D, Courillon C, Malacria M. Angew. Chem. Int. Ed. 2007; 46: 576
    • 3d Viveki AB, Mhaske SB. J. Org. Chem. 2018; 83: 8906
  • 4 Songsichan T, Promsuk J, Rukachaisirikul V, Kaeobamrung J. Org. Biomol. Chem. 2014; 12: 4571
    • 5a Clarke AK, Unsworth WP. Chem. Sci. 2020; 11: 2876
    • 5b Hussain A, Yousuf SK, Mukherjee D. RSC Adv. 2014; 4: 43241
    • 5c Sumi K, Inoue Y, Nishio M, Naito Y, Hosoya T, Suzuki M, Hidaka H. Bioorg. Med. Chem. Lett. 2014; 24: 831
    • 5d Kurouchi H, Ohwada T. J. Org. Chem. 2020; 85: 876
    • 5e Faulkner DJ. Nat. Prod. Rep. 1984; 1: 251
    • 5f Hussain AS, Yousuf K, Mukherjee D. RSC Adv. 2014; 4: 43241
    • 5g Vitaku E, Smith DT, Njardarson JT. J. Med. Chem. 2014; 57: 10257
    • 5h Hill JE, Matlock JV, Lefebvre Q, Cooper KG, Clayden J. Angew. Chem. Int. Ed. 2018; 57: 5788
    • 5i Chinthapally K, Massaro NP, Ton S, Gardner ED, Sharma I. Tetrahedron Lett. 2019; 60: 151253
    • 5j Stephens TC, Lodi M, Steer AM, Lin Y, Gill MT, Unsworth WP. Chem. Eur. J. 2017; 23: 13314
    • 6a Hall JE, Matlock JV, Ward JW, Gray KV, Clayden J. Angew. Chem. Int. Ed. 2016; 55: 11153
    • 6b Yang Y, Ying H, Li Z, Wang J, Chen Y, Luo B, Gray DL, Ferguson A, Chen QZ. Y, Cheng J. Nat. Commun. 2021; 12: 1572
  • 7 Abdel-Magid AF, Carson KG, Harris BD, Maryanoff CA, Shah RD. J. Org. Chem. 1996; 61: 3849
  • 8 Padiya KJ, Gavade S, Kardile B, Tiwari M, Bajare S, Mane M, Gaware V, Varghese S, Harel D, Kurhade S. Org. Lett. 2012; 14: 2814
  • 9 Lam PY. S, Ru Y, Jadhav PK, Aldrich PE, Delucca GV, Eyermann CJ, Chang C.-H, Emmett G, Holler ER, Daneker WF, Li L, Confalone PN, McHugh RJ, Han Q, Li R, Markwalder JA, Seitz SP, Sharpe TR, Bacheler LT, Rayner MM, Klabe RM, Shum L, Winslow DL, Kornhauser DM, Jackson DA, Erickson-Viitanen S, Hodge CN. J. Med. Chem. 1996; 39: 3514
  • 10 General Procedure B: Synthesis of Quinazolinones Prepared according to modified procedure reported by Songsichan.4 A sealed tube equipped with a magnetic stirring bar was charged with 2-iodobenzamides 1 (0.5 mmol), cyclic enaminones 2 (0.6 mmol), CuI (5 mol%), 1,2-trans-diaminocyclohexane (10 mol%), and K3PO4 (1.25 mmol) in THF (2.5 mL). The resulting mixture was stirred at 90 °C for 15 h. After that, the resulting mixture was cooled to room temperature, quenched with sat. NH4Cl, and extracted with EtOAc. The organic layer was dried over anhydrous Na2SO4, filtered, and concentrated. The residue was purified by column chromatography (CH2Cl2/EtOAc, 5:1) to provide quinazolinone products 3.
  • 11 Analytical Data for tert-Butyl {2-[4-Oxo-2-(4-oxopentyl)quinazolin-3(4H)-yl]ethyl}carbamate 3a Prepared according to general procedure B. Yield 88% as a white solid. 1H NMR (300 MHz, CDCl3): δ = 8.22 (d, J = 7.6 Hz, 1 H), 7.71 (t, J = 7.6 Hz, 1 H), 7.61 (d, J = 7.6 Hz, 1 H), 7.42 (t, J = 7.6 Hz, 1 H), 5.24 (br s, 1 H), 4.27 (t, J = 6.2 Hz, 2 H), 3.48 (q, J = 6.2 Hz, 2 H), 2.92 (t, J = 6.8 Hz, 2 H) 2.66 (t, J = 6.8 Hz, 2 H), 2.28–2.04 (m, 5 H), 1.38 (s, 9 H). 13C NMR (75 MHz, CDCl3): δ = 208.3, 162.6, 156.4, 156.2, 147.2, 134.2, 126.9, 126.6, 126.4, 120.3, 79.6, 43.1, 42.4, 39.2, 33.8, 30.0, 28.3, 21.0. IR (thin film): ν = 3258, 2935, 1710, 1666, 1593, 1366, 1250, 1170, 774 cm–1. HRMS (ESI): m/z [M + Na]+ calcd for C20H27N3O4: 396.1899; found: 396.1899.
  • 12 General Procedure C: Synthesis of Quinazolinone-Fused Eleven-Membered Ring Ureas To a solution of quinazolinone 3 (0.6 mmol) and benzylamine (0.9 mmol) in CH2Cl2 (6 mL) was added sodium triacetoxyborohydride (STABH, 1.2 mmol) and acetic acid (18.0 μL). The resulting mixture was stirred at room temperature under a N2 atmosphere for 24 h. After that, the resulting mixture was quenched by adding 1.0 N NaOH and extracted with CH2Cl2 (3 × 10.0 mL). The organic layer was dried over anhydrous Na2SO4, filtered, and concentrated. Then, to the crude mixture in CH2Cl2 (3.0 mL) was added trifluoroacetic acid (3.0 mL). The mixture was stirred at room temperature under a N2 atmosphere for 2 h. After that, the resulting mixture was quenched by adding 1.0 N NaOH and extracted with CH2Cl2 (3 × 10.0 mL). The organic layer was dried over anhydrous Na2SO4, filtered, and concentrated to give amine crude. Then, the crude mixture in t-BuOH (30.0 mL) was stirred at room temperature. CDI (0.72 mmol) was added in the reaction mixture at room temperature and stirred at room temperature for 18 h. After that, t-BuOH was evaporated in vacuo. The resulting mixture was quenched with sat. NH4Cl and extracted with EtOAc (3 × 10.0 mL). The organic layer was dried over anhydrous Na2SO4, filtered, and concentrated. The residue was purified by column chromatography (EtOAc/MeOH, 9:1) to provide quinazolinone-fused eleven-membered-ring ureas 5.
  • 13 Analytical Data for 5-Benzyl-6-methyl-2,3,6,7,8,9-hexahydro-[1,3,6]triazacycloundecino[7,6-b]quinazoline-4,15(1H,5H)-dione (5a) Prepared according to general procedure C. Yield 60% as a white solid. 1H NMR (300 MHz, CDCl3 + CD3OD 2 drops): δ = 8.25 (d, J = 7.5 Hz, 1 H), 7.71 (t, J = 7.5 Hz, 1 H), 7.59 (d, J = 7.5 Hz, 1 H), 7.43 (t, J = 7.5 Hz, 1 H), 7.42–7.45 (m, 5 H), 4.78 (d, J = 14.7 Hz, 1 H), 4.58 (d, J = 14.4 Hz, 1 H), 4.45 (m, 1 H), 4.30 (d, J = 14.7 Hz, 1 H), 4.20–4.05 (m, 2 H), 3.53–3.38 (m, 1 H), 3.36–3.20 (m, 1 H), 2.96–2.80 (m, 1 H), 2.63–2.52 (m, 1 H), 2.45–2.28 (m, 1 H), 1.70–1.52 (m, 1 H), 1.51–1.38 (m, 1 H), 1.20–1.11 (m, 1 H), 1.07 (d, J = 6.9 Hz, 3 H). 13C NMR (75 MHz, CDCl3 + CD3OD 2 drops): δ = 162.7, 158.2, 158.0, 147.3, 139.0, 134.5, 129.0, 128.6 (3 C), 127.7, 126.8 (2 C), 126.5, 120.2, 54.5, 52.8, 43.8, 40.3, 31.4, 30.8, 24.5, 20.1. IR (thin film): ν = 3351, 2931, 1661, 1537, 1453, 1305, 1167, 769, 728, 698 cm–1. HRMS (ESI): m/z [M + H]+ calcd for C23H26N4O2: 391.2129; found: 391.2129.